| Drug Name: | Lidoflazine (3416-26-0) |
|---|---|
| PubChem ID: | 3926 |
| SMILES: | CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F |
| InchiKey: | ZBIAKUMOEKILTF-UHFFFAOYSA-N |
| Therapeutic Category: | Calcium Channel Blockers, Cardiovascular Agents, Membrane Transport Modulators, Vasodilator Agents |
| Molecular Weight (dalton) | : | 491.626 |
| LogP | : | 5.75004 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 35.58 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Tachycardia Ventricular | MetaADEDB |
| Ventricular Fibrillation | MetaADEDB |